EcoDrugPlus

Ensembl ID : ML033625a
Gene Symbol: -
External references: -
206 Possible Orthologues:

Ensembl ID : ML034315a
Gene Symbol: -
External references: -
259 Possible Orthologues:

Ensembl ID : ML03454a
Gene Symbol: -
External references: -
80 Possible Orthologues:

Ensembl ID : ML034626a
Gene Symbol: -
External references: -
60 Possible Orthologues:

Ensembl ID : ML034637a
Gene Symbol: -
External references: -
137 Possible Orthologues:

Ensembl ID : ML034656a
Gene Symbol: -
External references: -
186 Possible Orthologues:

Ensembl ID : ML03472a
Gene Symbol: -
External references: -
182 Possible Orthologues:

Ensembl ID : ML03509a
Gene Symbol: -
External references: -
203 Possible Orthologues:

Ensembl ID : ML03538a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML03543a
Gene Symbol: -
External references: -
119 Possible Orthologues:

Ensembl ID : ML03612a
Gene Symbol: -
External references: -
122 Possible Orthologues:

Ensembl ID : ML050915a
Gene Symbol: -
External references: -
47 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).